PTC THERAPEUTICS, INC. (PTCT) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US69366J2006
PTC THERAPEUTICS, INC. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 1.73 bn USD |
| Operating income | 866.94 m USD |
| EBIT | 696.62 m USD |
| Net income | 682.64 m USD |
| Diluted EPS – continuing operations | 7.78 USD |
Full history since 2004, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About PTC THERAPEUTICS, INC.
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally. The company provides Translarna and Emflaza for the treatment of Duchenne muscular dystrophy; Upstaza to treat aromatic l-amino acid decarboxylas (AADC) deficiency, a central nervous system disorder; Tegsedi and Waylivra for the treatment of rare diseases; and Evrysdi to treat spinal muscular atrophy (SMA) in adults and children. Its development pipeline products include Sepiapterin for the treatment of phenylketonuria; PTC518 splicing platform, which is being developed for the treatment of Huntington's disease; and inflammation and ferroptosis platforms, including vatiquinone to treat Friedreich's ataxia. The company distributes its products through third-party distributors. It has collaborations with F. Hoffman-La Roche Ltd., Hoffman-La Roche Inc., the SMA Foundation, National Taiwan University, Akcea Therapeutics, Inc., and Shiratori Pharmaceutical Co., Ltd. The company has license and collaboration agreement with Novartis Pharmaceuticals Corporation to develop PTC518 Huntington's disease program. It markets Upstaza, a gene therapy with the brand name Kebilidi in the United States. PTC Therapeutics, Inc. was incorporated in 1998 and is headquartered in Warren, New Jersey.
More stocks
- Banco Itau Chile (ITAUCL.SN)
- NEW JERSEY RESOURCES CORP (NJR)
- Nanjing Tanker Corp (601975.SS)
- Guangzhou Friendship Group Co Ltd (000987.SZ)
- Scholar Rock Holding Corp (SRRK)
- MATERION Corp (MTRN)
- West Fraser Timber Co Ltd (WFG.TO)
- Teleperformance SE (TEP.PA)
- Gecina SA (GFC.PA)
- Archrock, Inc. (AROC)
- CNX Resources Corp (CNX)
- Vallourec SA (VK.PA)
Not investment advice. All data without warranty, price as of 21.10.2026. Details in the risk notice.